In the present study, we determined the association between serum FGF23 levels and cognitive performance, structural MRI brain measures predictive of dementia, and clinically confirmed, new-onset all-cause dementia and Alzheimer’s disease (AD), in a large, community-based, prospective cohort. This evidence concerns the gene FGF23 and Alzheimer disease.